Sabiedrība ar ierobežotu atbildību "Inpharmatis Group"
Copy
Copy
CopyRegistry data
Legal status
Company ID
CopyVAT code
CopyIncorporation date
Paid share capital
Registered share capital
Contacts
Company registration address
Copy
Website
-Latest events
from (18/11/2021)
2026-04-08
Change in securing measures2026-03-25
Change in securing measures2025-02-24
Change in securing measures2025-02-04
Change of legal addressSuspensions
Type of suspension (date)
Economic activity suspended (2026-04-08)Result of suspension (date)
-
Register and unlock the potential of dataReliability
Register and check the change of employees’ number over the years
Number of employees
12Debts
209,325.33 €
+193,107.17 €* during past year
Register and check if company had lawsuits over the years
Lawsuits as defendant
4
Credit limit
***** €
Turnover
200-500 k €
-23.41 %Business linkages
1Linkages with other companies
Financial ratios
Net Profit (€)
-259,836
EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization and is a metric used to evaluate a company’s operating performance. It can be seen as a proxy for cash flow from the entire company’s operations.EBITDA margin (%)
Enjoy unlimited use
with Freemium unlimitedEBIT margin shows the profitability of a company over a certain period of time.EBIT margin (%)
Enjoy unlimited use
with Freemium unlimitedNet Profit (€)
-259,836EBITDA margin (%)
Enjoy unlimited use
with Freemium unlimitedEBIT margin (%)
Enjoy unlimited use
with Freemium unlimitedFinancial statement report
Premium users: 1.00 credit
| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€)Sales per employee is a popular efficiency indicator that is often used to measure a company's performance. The average annual number of employees is usually used to calculate the indicator. |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€)This ratio is on of company's growth indicators. It shows how much profit per employee is earned by the company. |
| Total profitability (%)It is an indicator of company's performance efficiency, calculated as ratio of gross profit to sales revenue. |
| Net profitability (%)This ratio is commonly referred to as a company’s “bottom line” and is a true indicator of a company’s profitability. It shows how much a net profit of € 1 (or other monetary unit) is generated by sales. |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| Current Assets (€) |
| Working capital requirement (%)The working capital requirement indicator shows how much funds a company needs to develop and maintain a business. |
| Debt-to-equity ratioThe debt-to-equity ratio is used to evaluate a company's financial leverage and is calculated by dividing a company’s total liabilities by its shareholder equity.
This ratio is a measure of the degree to which a company is financing its operations through debt versus wholly owned funds. More specifically, it reflects the ability of shareholder equity to cover all outstanding debts in the event of a business downturn. |
| EBITDA margin (%)EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization and is a metric used to evaluate a company’s operating performance. It can be seen as a proxy for cash flow from the entire company’s operations. |
| EBITDA (€)EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. Lenders use EBITDA to calculate a company’s ability to repay a loan and pay interest. |
| EBIT margin (%)EBIT margin shows the profitability of a company over a certain period of time. |
| EBIT (€)EBIT (earnings before interest and taxes) is a company's net income before income tax expense and interest expenses are deducted. EBIT is used to analyze the performance of a company's core operations without the costs of the capital structure and tax expenses impacting profit. |
| 2022 |
|---|
| 627,052 |
| 89,579 |
| 21,511 |
| 21,499 |
| 3,071 |
| 2.95 |
| 3.43 |
| 24,327 |
| 933,086 |
| 1,895 |
| 955,518 |
| 2023 |
|---|
| 383,978 |
| 54,854 |
| 67,209 |
| 67,209 |
| 9,601 |
| -6.99 |
| 17.50 |
| 70,037 |
| 917,532 |
| 877 |
| 986,692 |
| 2024 |
|---|
| 294,102 |
| 24,509 |
| -259,836 |
| -259,836 |
| -21,653 |
| -91.21 |
| -88.35 |
| 354,823 |
| 433,783 |
| 1,607 |
| 786,999 |
Enjoy unlimited use
with Freemium unlimited| 2024 |
|---|
| 294,102 |
| 24,509 |
| -259,836 |
| -259,836 |
| -21,653 |
| -91.21 |
| -88.35 |
| 354,823 |
| 433,783 |
| 1,607 |
| 786,999 |
Enjoy unlimited use
with Freemium unlimitedTurnover (€)
2024
Turnover (€)
294,102 €
-23 % *
Sales per employee (€)
24,509 €-55 % *
Profit before tax (€)
-259,836 €-487 % *
Net Profit (€)
-259,836 €-487 % *
Profit per employee (€)
-21,653 €-326 % *
Total profitability (%)
-91.21 %-1,204.86 % *
Net profitability (%)
-88.35 %-604.86 % *
Equity (€)
354,823 €
407 % *
Amounts Payable And Liabilities (€)
433,783 €
-53 % *
Non-current Assets (€)
1,607 €
83 % *
Current Assets (€)
786,999 €-20 % *
Credit history
No. of unpaid debts
1
Largest debt
VID
Amount of unpaid debts
€209,325.33
Oldest open debt
-
No. of unpaid debts
1
Largest debt
VID
Amount of unpaid debts
€209,325.33
Oldest open debt
-
Credit report
Creditor/Data source  | Debt amount | Debt date | Debt type |
|---|---|---|---|
- | - | - | - |
Creditor/Data source | Debt amount | Debt date | Payment date | Debt type |
|---|---|---|---|---|
- | - | - | - | - |
Legal proceedings
Defendant
(5)
Plaintiff
(0)
Case No./date | Process parties | Case/Court ruling | Court | No. of court hearings | More |
|---|---|---|---|---|---|
14/06/2026C771158926C-11589-26 | Claimant:Individual person Respondent:Sabiedrība ar ierobežotu atbildību "Inpharmatis Group" | Reason: vienkāršotās procedūras lieta par naudas piedziņu Decision: Open | Rīgas pilsētas tiesa | 1 |  |
01/06/2026C771145726C-11457-26 | Claimant:Individual person Respondent:Sabiedrība ar ierobežotu atbildību "Inpharmatis Group" | Reason: par darba tiesisko attiecību izbeigšanas fakta atzīšanu, darba samaksas, atvaļinājuma kompensācijas, atlaišanas pabalsta, mantiskā un morālā kaitējuma atlīdzību Decision: Open | Rīgas pilsētas tiesa | 1 | |
13/05/2026C771163626C-11636-26 | Claimant:Individual person Claimant:Individual person | Reason: maksātnespējas procesa pieteikums Decision: Open | Rīgas pilsētas tiesa | 2 |  |
10/03/2026C771019224C-00932-26 | Claimant:SIA "UNIFARMA" Respondent:Sabiedrība ar ierobežotu atbildību "Inpharmatis Group" | Reason: naudas atmaksa un līguma izpilde Decision: Open | Rīgas pilsētas tiesa | 1 | |
10/09/2025C771019224C-02443-25 | Claimant:SIA "UNIFARMA" Respondent:Sabiedrība ar ierobežotu atbildību "Inpharmatis Group" | Reason: naudas atmaksa un līguma izpilde Decision: Open | Rīgas pilsētas tiesa | 3 | |
Case No./date | Process parties | Case/Court ruling | Court | No. of court hearings | More |
|---|---|---|---|---|---|
| - | - | - | - | - | - |
Public data
Data source | Information | Additional data |
|---|---|---|
 | Total amount of taxes administered by the SRS and paid by taxpayers within the tax year 2022 | Total amount: 84,020 |
| Total amount of taxes administered by the SRS and paid by taxpayers within the tax year 2021 | Total amount: 117,890 |
| Total amount of taxes administered by the SRS and paid by taxpayers within the tax year 2020 | Total amount: 35,030 |
| Total amount of taxes administered by the SRS and paid by taxpayers within the tax year 2019 | Total amount: 20,250 |
| Total amount of taxes administered by the SRS and paid by taxpayers within the tax year 2018
| Total amount: 130,450 |
Similar companies
Category:
Research and experimental development in natural sciences and engineeringComp. code:
42103105522Reg. date:
04/02/2020Turnover:
-No. of employees:
12Category:
Research and experimental development in natural sciences and engineeringComp. code:
40103991025Reg. date:
06/05/2016Turnover:
-No. of employees:
8Category:
Research and experimental development in natural sciences and engineeringComp. code:
40103884728Reg. date:
27/03/2015Turnover:
-No. of employees:
10Category:
Research and experimental development in natural sciences and engineeringComp. code:
41203052082Reg. date:
10/07/2014Turnover:
-No. of employees:
15
Category:
Research and experimental development in natural sciences and engineeringComp. code:
40103594297Reg. date:
09/10/2012Turnover:
-No. of employees:
8Frequently Asked Questions
What is the current status of Sabiedrība ar ierobežotu atbildību "Inpharmatis Group"?
Sabiedrība ar ierobežotu atbildību "Inpharmatis Group" is currently Registered. It was registered on 28/05/2013.
What is Sabiedrība ar ierobežotu atbildību "Inpharmatis Group" registered address?
Sabiedrība ar ierobežotu atbildību "Inpharmatis Group" registered address is Ģertrūdes iela 7, Rīga, LV-1010.
What is Sabiedrība ar ierobežotu atbildību "Inpharmatis Group" activity?
Sabiedrība ar ierobežotu atbildību "Inpharmatis Group" operates in Research and experimental development in natural sciences and engineering (72.10 - NACE 2.1).
How many employees does Sabiedrība ar ierobežotu atbildību "Inpharmatis Group" have?
Sabiedrība ar ierobežotu atbildību "Inpharmatis Group" has 12 employees (2024).
Is Sabiedrība ar ierobežotu atbildību "Inpharmatis Group" a reliable company?
Sabiedrība ar ierobežotu atbildību "Inpharmatis Group" Pre-Score* rating is E, which indicates a very low level of reliability.
* The credit score is calculated based on financial data, payment history, and other risk indicators.What is the annual turnover of Sabiedrība ar ierobežotu atbildību "Inpharmatis Group"?
Sabiedrība ar ierobežotu atbildību "Inpharmatis Group" reported a turnover of 294,102 EUR in 2024.
Does Sabiedrība ar ierobežotu atbildību "Inpharmatis Group" have any current state debt?
Sabiedrība ar ierobežotu atbildību "Inpharmatis Group" currently has an outstanding state debt of 209,325.33 €.